Skadden Assumes Top Spot for M&A Deals in 2014
Summary: Skadden has moved back into the top spot for mergers and acquisitions in 2014 after finishing seventh in 2013. Skadden,…
Valeant Pharmaceuticals Inc.
Valeant Pharmaceuticals International Inc. Offers to Buy Botox Giant Allergan Inc.
In a cash-and-stock deal valued at $45.7 billion, Valeant Pharmaceuticals Inc. would give Allergan investors $48.30 in cash and 0.83…